Results 321 to 329 of about 126,024 (329)

Sorafenib

Reactions Weekly, 2014
openaire   +2 more sources

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Gut, 2020
Matsatoshi Kudo, Masafumi Ikeda, Takuji Torimura   +2 more
exaly  

Molecular therapies and precision medicine for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2018
, Daniela Sia, Richard S Finn
exaly  

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Lancet, The, 2011
Brian I Rini, Andrey Kaprin, C?zary A Szczylik   +2 more
exaly  

Sorafenib

Reactions Weekly, 2018
openaire   +2 more sources

Advances in targeted therapies for hepatocellular carcinoma in the genomic era

Nature Reviews Clinical Oncology, 2015
Josep M Llovet, Augusto Villanueva, Anja Lachenmayer   +2 more
exaly  

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Journal of Clinical Oncology, 2006
Ghassan K Abou-Alfa, Armando Santoro, Jacques De Greve   +2 more
exaly  

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Nature Reviews Drug Discovery, 2006
Brian Schwartz
exaly  

Sorafenib

Reactions Weekly
openaire   +1 more source